Page last updated: 2024-08-21

imperatorin and Dyslipidemia

imperatorin has been researched along with Dyslipidemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bunbupha, S; Maneesai, P; Pakdeechote, P; Poasakate, A; Prasarttong, P	1

Other Studies

1 other study(ies) available for imperatorin and Dyslipidemia

Article	Year
Imperatorin alleviates metabolic and vascular alterations in high-fat/high-fructose diet-fed rats by modulating adiponectin receptor 1, eNOS, and p47 European journal of pharmacology, 2021, May-15, Volume: 899 Topics: Animals; Aorta, Thoracic; Diet, High-Fat; Dietary Sugars; Disease Models, Animal; Dyslipidemias; Fructose; Furocoumarins; Hemodynamics; Hypertension; Insulin Resistance; Male; Metabolic Syndrome; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type III; Obesity; Oxidative Stress; Rats, Sprague-Dawley; Receptors, Adiponectin; Signal Transduction	2021

Article

Year

Imperatorin alleviates metabolic and vascular alterations in high-fat/high-fructose diet-fed rats by modulating adiponectin receptor 1, eNOS, and p47

European journal of pharmacology, 2021, May-15, Volume: 899

Topics: Animals; Aorta, Thoracic; Diet, High-Fat; Dietary Sugars; Disease Models, Animal; Dyslipidemias; Fructose; Furocoumarins; Hemodynamics; Hypertension; Insulin Resistance; Male; Metabolic Syndrome; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type III; Obesity; Oxidative Stress; Rats, Sprague-Dawley; Receptors, Adiponectin; Signal Transduction

2021